öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÕԾôï
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º82

ËùÊôԺУ£ºÇຣ´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×Áöѧ
Ñо¿ÁìÓò£º ÁÙ´²Ò½ÁƼ¼ÄÜѵÁ·ÓëÑо¿
Ñо¿ÁìÓò£º ÁÙ´²Ò½ÁƼ¼ÄÜѵÁ·ÓëÑо¿ [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÀú£º
ÕԾô˶ʿѧÀú£¬ÔÚ¶Á²©Ê¿£¬ÏÖÈÎÖйú¿¹°©Ð­»áίԱ£¬Çຣʡ¿¹°©Ð­»áίԱ£¬ÖйúÃâÒßѧ»áÀíÊ¡£Ö÷ÒªÑо¿·½ÏòΪ£º¶ñÐÔÖ×ÁöµÄÁÙ´²ºÍ»ù´¡Ñо¿¡£

½ÌÓý¾­Àú£º

2014.8-±±¾©Ð­ºÍҽѧԺ£¬Öйúҽѧ¿ÆѧԺÖ×ÁöÒ½ÔºÄÚ¿ÆÈ«ÈÕÖƲ©Ê¿ÔÚ¶Á

2003/9 - 2006/7£¬Çຣ´óѧҽѧԺ£¬ÃâÒßѧ£¬Ë¶Ê¿£¬µ¼Ê¦£º¹¢ÅÅÁ¦

1994/9 - 1999/7£¬Çຣ´óѧҽѧԺ£¬ÁÙ´²Ò½Ñ§£¬Ñ§Ê¿

¹¤×÷¾­Àú£º

2015.12-Çຣ´óѧ¸½ÊôÒ½Ôº£¬Ö×ÁöÄÚ¿Æ£¬Ö÷ÈÎҽʦ£¬¸±½ÌÊÚ

2011/12 -£¬Çຣ´óѧ¸½ÊôÒ½Ôº£¬Ö×ÁöÄÚ¿Æ£¬¸±½ÌÊÚ

2010/12 -2015.12£¬Çຣ´óѧ¸½ÊôÒ½Ôº£¬Ö×ÁöÄÚ¿Æ£¬¸±Ö÷ÈÎҽʦ

2005/12 - 2010/11£¬Çຣ´óѧ¸½ÊôÒ½Ôº£¬Ö×ÁöÄÚ¿Æ£¬Ö÷ÖÎҽʦ

1999/7 -2005/11£¬Çຣ´óѧ¸½ÊôÒ½Ôº£¬Ö×ÁöÄÚ¿Æ£¬Ò½Ê¦
»ñ½±Çé¿ö£º
Ò»¡¢¿ÆÑгɹû

ÇຣµØÇø²Ø¡¢»Ø¡¢ºº×åIL-1BºÍIL-1RN»ùÒò¶à̬ÐÔ¼°Óëθ°©µÄÏà¹ØÐÔÑо¿£¬Çຣʡ¿Æ¼¼Ìü£¬³É¹ûÆÀ¼Û£¬¹ú¼ÊÏȽø£¬ÅÅÃûµÚÒ»£¬2014¡£



¿ÆÑй¤×÷ :
Ñо¿ÄÚÈݼò½é£º
Ö÷Òª´ÓʸßÔ­µØÇøθ°©ÁÙ´²ºÍ»ù´¡Ïà¹ØÑо¿¡£Èç½øÐÐÁËÇຣµØÇø²Ø¡¢»Ø¡¢ºº×åθ°©µÄÑо¿£¬·¢ÏÖÇຣʡÕâÈý¸öÃñ×åθ°©»¼Õß¹¹³É¾ùÒÔ35-60ËêΪÖ÷£¬µ«ÊÇÃñ×å¼ä»¼²¡ÄêÁ䲻ͬ£¬·¢²¡²¿·ÖÓÐÇø±ðµÈ¡£½øÒ»²½½øÐÐÁ˲Ø¡¢»Ø¡¢ºº×åθ°©ÒÅ´«Ñ§µÄ³õ²½Ñо¿£¬Ö÷Òª½øÐÐÁËIL-1 B£¬IL ¨CRN,PSCAµÈ¿ÎÌâµÄÑо¿¡£·¢ÏÖ IL-1BºÍIL -RN »ùÒò¶à̬ÐÔÓëÇຣµØÇø²Ø¡¢»Ø¡¢ºº×å ²Ø×åθ°©³ÊÏà¹ØÐÔ£¬µ«Æäλµã²»ÍêÈ«Ò»Ö¡£ÔÚ´Ë»ù´¡ÊÇ£¬½øÐиßÔ­µØÇøθ°©·¢²¡»úÖÆÑо¿¼°Ïà¹ØÁÙ´²Ñо¿¡£È翪չEPAS1µÍÑõ·´Ó¦Í¨Â·²ÎÓë¸ßÔ­µÍÑõ»·¾³ÏÂθ°©·¢²¡»úÖÆÑо¿£¬¸ßº£°Î¶Ôθ°©·¢²¡ÁÙ´²²¡ÀíÌØÕ÷¼°Ô¤ºóµÄÓ°ÏìµÈµÈ¡£
ÔÚÑпÆÑÐÏîÄ¿£º
1.2013 Äê¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¿ÎÌ⡶ EPAS1 £¨ HIF-2¦Á£© µÍÑõ·´Ó¦Í¨Â·²ÎÓë¸ßÔ­µÍÑõ»·¾³ÏÂθ°©·¢²¡»úÖÆÑо¿¡·¡£ÏîÄ¿±àºÅ£º **£¬ÆðÖ¹ÄêÔ£º2014/07-2017/12£¬50Íò£¬ÔÚÑУ¬±¾ÈËΪÖ÷³Ö¡£

2.Çຣʡ¿Æ¼¼ÌüÏîÄ¿£¬2014-Z-745£¬¡¶¸ßÔ­ÈËȺθ°©°ÐÏòµ°°×ÖÊ·Ö×Ó±êÖ¾ÎïµÄɸѡÓë ¼ø¶¨¡·£¬ÆðÖ¹ÄêÔ£º2014/07-2017/12£¬20Íò£¬ÔÚÑУ¬µÚ¶þ²ÎÓëÈË¡£

3.2008¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¶ÇຣµØÇø²Ø¡¢»Ø¡¢ºº×å IL-1B ºÍ IL-1RN »ùÒò¶à̬ÐÔ¼°Óëθ°©µÄÏà¹ØÐÔÑо¿¡·£¬ÏîÄ¿±àºÅ£º **£¬Æðֹʱ¼ä£º 2009 Äê 1 ÔÂÖÁ 2011 Äê 12 Ô£¬ÆðÖ¹ÄêÔ£º2014/07-2017/12£¬25Íò£¬ÒѽáÌ⣬±¾ÈËΪÖ÷³Ö¡£

4. ÇຣÊ¡£¨Ó¦Óã©»ù´¡Ñо¿¼Æ»®ÏîÄ¿£¬2012-Z-739£¬¡¶Çຣ²Ø¡¢»Ø¡¢ºº×åPLCE1 SNPsÓëθ°©µÄÏà¹ØÐÔÑо¿¡·£¬2012/06-2015/12£¬10ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£

5. Çຣ´óѧÖÐÇàÄê¿ÆÑлù½ð¿ÎÌ⣬2009-QY-17£¬¡¶ÇຣµØÇø²Ø×åPSCA»ùÒò¶à̬ÐÔ¼°ÆäÓëθ°©µÄÏà¹ØÐÔÑо¿¡·£¬2009/01-2010/12£¬2ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£
ѧÊõÂÛÎÄ£º
Ò»¡¢±¾ÈË·¢±íÂÛÎÄ£¨½ü5Äê·¢±íµÄÎÄÕ£©

[1] Zhao JD, Geng PL, Li ZQ, et al. Associations between interleukin-1 polymorphisms and gastric cancers among three ethnicities. World J Gastroenterol. 2012. 18(47): 7093-9.

[2] Zhao J, Geng P, Li Z, et al. Prostate stem cell antigen rs** polymorphism differentially contributes to -negative gastric cancer among various populations in China. Mol Clin Oncol. 2013. 1(3): 493-498.

[3] Du F, Zheng Z, Shi S, et al. S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial. Medicine (Baltimore). 2015. 94(23): e958.

[4] Du F, Yuan P, Wang T, et al. The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review. Med Res Rev. 2015. 35(6): 1300-15.

[5] Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors. Cancer Treat Rev. 2015. 41(7): 623-33.

[6] Zhao J, Du F, Shen G, Zheng F, Xu B. The role of hypoxia-inducible factor-2 in digestive system cancers. Cell Death Dis. 2015. 6: e1600.

[7] Zhao J, Zhao J, Du F, et al. Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China. J Gastrointest Surg. 2016 .

[8] Zheng F, Du F, Zhao J. Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2alpha Expression for Gastric Cancer: Evidence From Meta-Analysis. Medicine (Baltimore). 2016. 95(7): e2871.

[9] Zhao J, Bai Z, Feng F, et al. Cross-talk between EPAS-1/HIF-2alpha and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell. Int J Biochem Cell Biol. 2016. 72: 73-88.

¶þ¡¢Ñо¿Éú·¢±íÂÛÎÄ£¨°´ÐòºÅ¡¢Ç°Èý×÷ÕßÐÕÃû¡¢ÂÛÎÄÌâÄ¿¡¢·¢±í¿¯ÎïÃû³Æ¡¢·¢±íʱ¼ä·ÖÐÐÌîд£¬ÏÞ10ƪ£©

[1] Zheng F, Du F, Zhao J. Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2alpha Expression for Gastric Cancer: Evidence From Meta-Analysis. Medicine (Baltimore). 2016. 95(7): e2871.